Business
Shoulder Innovations Reports First Quarter 2026 Financial Results and Raises Full Year Outlook
Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the first quarter ended March 31, 2026.
About this update from Shoulder Innovations, Inc.
[{"type":"text","content":"Generates First Quarter Net Revenue Growth of 65% Year-Over-Year","length":64,"tagName":"p","attribs":{}},{"type":"text","content":"GRAND RAPIDS, Mich., May 13, 2026 /PRNewswire/ -- Shoulder Innovations, Inc. (Shoulder Innovations, or the company) (NYSE: SI), a commercial-stage medical technology company exclusively focused on transforming the shoulder surgical care market, today reported financial results for the first quarter ended March 31, 2026.","length":321,"tagName":"p"},{"type":"image","alt":"Shoulder Innovations company logo (PRNewsfoto/Shoulder Innovations)","displaySize":"","headline":null,"caption":"Shoulder Innovations company logo (PRNewsfoto/Shoulder Innovations)","className":"","disableSlideshowImg":false,"size":{"original":{"width":400,"height":107,"url":"https://media.zenfs.com/en/prnewswire.com/377927e19f436c59c7ed5d283b312fcd"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/fq.AeExVFJ1fscrmJ5l.rA--/YXBwaWQ9aGlnaGxhbmRlcjt3PTcwNTtoPTE4OQ--/https://media.zenfs.com/en/prnewswire.com/377927e19f436c59c7ed5d283b312fcd","width":400,"height":107},"resize_sm":{"url":"https://s.yimg.com/ny/api/res/1.2/mIvKFoJ8aQrj6xC.zCQB1Q--/YXBwaWQ9aGlnaGxhbmRlcjt3PTY0MDtoPTE3MQ--/https://media.zenfs.com/en/prnewswire.com/377927e19f436c59c7ed5d283b312fcd","width":400,"height":107}},"href":"https://mma.prnewswire.com/media/2820094/Shoulder_Innovations_Logo.html","hrefExternal":true,"rel":"nofollow"},{"type":"text","content":"First Quarter Financial Highlights","length":34,"tagName":"p"},{"type":"list","items":[{"val":[{"type":"text","content":"Generated net revenue of $16.7 million in the first quarter, a 65% increase over the first quarter of 2025","length":106,"tagName":"p"}]},{"val":[{"type":"text","content":"Achieved gross margin of 77.7% for the first quarter compared to 76.9% for the first quarter of 2025","length":100,"tagName":"p"}]},{"val":[{"type":"text","content":"Increased average selling price of our implant systems to $7,650 in the first quarter, a 9% increase over the first quarter of 2025","length":131,"tagName":"p"}]},{"val":[{"type":"text","content":"Increased full year 2026 net revenue guidance to $65 million to $68 million, representing growth of approximately 37% to 44% over full year 2025 net revenue","length":156,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":493,"olType":false},{"type":"text...